Transitioning patients with type 1 diabetes from multiple daily injections (MDI) to continuous subcutaneous insulin infusion (CSII)

被引：0
|
作者：
Kumar, RP
Hirsch, IB
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A110 / A110
页数：1
相关论文
共 50 条
  • [21] Effects of Insulin Therapy with Continuous Subcutaneous Insulin Infusion (CSII) in Diabetic Patients: Comparison with Multi-daily Insulin Injections Therapy (MDI)
    Derosa, Giuseppe
    Maffioli, Pamela
    D'Angelo, Angela
    Salvadeo, Sibilla A. T.
    Ferrari, Ilaria
    Fogari, Elena
    Mereu, Roberto
    Gravina, Alessia
    Palumbo, Ilaria
    Randazzo, Sabrina
    Cicero, Arrigo F. G.
    ENDOCRINE JOURNAL, 2009, 56 (04) : 571 - 578
  • [22] The efficacy of continuous subcutaneous insulin infusion and multiple daily injections of insulin in pregnant women with type 1 diabetes
    Hebda-Szydlo, A.
    Cyganek, K.
    Malecki, M. T.
    Trznadel-Morawska, I.
    Katra, B.
    Klupa, T.
    Kaim, I.
    Reron, A.
    Sicradzki, J.
    DIABETOLOGIA, 2008, 51 : S456 - S457
  • [23] Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years
    Jakisch, B. I.
    Wagner, V. M.
    Heidtmann, B.
    Lepler, R.
    Holterhus, P-M.
    Kapellen, T. M.
    Vogel, C.
    Rosenbauer, J.
    Holl, R. W.
    DIABETIC MEDICINE, 2008, 25 (01) : 80 - 85
  • [24] Multiple daily injections of insulin versus continuous subcutaneous insulin infusion for pregnant women with type 1 diabetes
    Wender-Ozegowska, Ewa
    Zawiejska, Agnieszka
    Ozegowska, Katarzyna
    Wroblewska-Seniuk, Katarzyna
    Iciek, Rafal
    Mantaj, Urszula
    Olejniczak, Danuta
    Brazert, Jacek
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2013, 53 (02): : 130 - 135
  • [25] Difference in Insulin Usage Patterns with Pubertal Development in Children with Type 1 Diabetes During Transition from Multiple Daily Injections to Continuous Subcutaneous Insulin Infusion (CSII) and Through the CSII Treatment
    Shashaj, B.
    Sulli, N.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 (12) : 767 - 774
  • [26] Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Pregnant Women with Type 1 Diabetes
    Gonzalez-Romero, Stella
    Gonzalez-Molero, Inmaculada
    Fernandez-Abellan, Micaela
    Dominguez-Lopez, Marta E.
    Ruiz-de-Adana, Soledad
    Olveira, Gabriel
    Soriguer, Federico
    DIABETES TECHNOLOGY & THERAPEUTICS, 2010, 12 (04) : 263 - 269
  • [27] Continuous subcutaneous insulin infusion (CSII) in patients with Type 2 diabetes
    Lenhard, MJ
    Maser, RE
    DIABETES, 2001, 50 : A440 - A441
  • [28] Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI)
    Bruttomesso, D.
    Bonomo, M.
    Costa, S.
    Dal Pos, M.
    Di Cianni, G.
    Pellicano, F.
    Vitacolonna, E.
    Dodesini, A. R.
    Tonutti, L.
    Lapolla, A.
    Di Benedetto, A.
    Torlone, E.
    DIABETES & METABOLISM, 2011, 37 (05) : 426 - 431
  • [29] Level of glycemic control and pregnancy outcome in type-1 diabetes: A comparison between multiple daily injections (MDI) and continuous subcutaneous insulin infusions (CSII)
    Chen, Rony
    Yogev, Yariv
    Weissman-Brenner, Alina
    Haroush, Avi Ben
    Hod, Moshe
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (06) : S132 - S132
  • [30] Continuous subcutaneous insulin infusion (CSII) in children with type 1 diabetes
    Tamborlane, William V.
    Sikes, Kristin A.
    Steffen, Amy T.
    Weinzimer, Stuart A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 74 : S112 - S115
12345